Mild Parkinsonism in Persons Exposed to 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)
Neurol 39:1483-1487, Tetrud,J.W.,et al, 1989
Permanent Human Parkinsonism Due to 1-Methyl-4-Phenyl-1, 2, 3, 6-Tetrahydropyridine (MPTP) :Seven Cases
Neurol 35:949-956, Ballard,P.A.,et al, 1985
Tremor in MPTP-Induced Parkinsonism
Neurol 42:407-410, Tetrud,J.W.&Langston,J.W., 1992
Recovery From Experimental Parkinsonism in Primates with GM1 Ganglioside Treatment
Science 256:843-846, Schneider,J.S.,et al, 1992
Bilateral Fetal Mesencephalic Grafting in Two Patients with Parkinsonism Induced by MPTP
NEJM 327:1556-1563, 15891992., Widner,H.,et al, 1992
MPTP:A Neurotoxin Relevant to the Pathophysiology of Parkinson's Disease, The 1985 George Cotzias Lecture
Neurol 36:250-258, Snyder,S.H.&D'Amato,R.J., 1986
Locus Ceruleus Lesions & Eosinophilic Inclusions in MPTP-Treated Monkeys
Ann Neurol 20:449-455, Forno,L.S.,et al, 1986
The Clinical Syndrome of Striatal Dopamine Deficiency, Parkinsonism Induced by MPTP
NEJM 312:1418-1421, Burns,R.S.,et al, 1985
Chronic Parkinsonism Secondary to Intranasal Administration of a Product of Meperidine-Analogue Synthesis
NEJM 310:325, Wright,J.M.,et al, 1984